Aprea Therapeutics is headquartered in Doylestown, Pennsylvania.
Aprea Therapeutics has 8 employees.
Aprea Therapeutics is a life science company.
Aprea Therapeutics was founded in 2006.
3805 Old Easton Rd.,
Doylestown, Pennsylvania
18902
United States,
(215) 948-4119
www.aprea.com
Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company’s lead product candidate is APR-246, a small molecule in clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Aprea Therapeutics was founded in 2006 and is headquartered in Doylestown, Pennsylvania.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
| Financial | Deals |
|---|---|
|
Wedbush Securities |
1 |
| Legal | Deals |
|---|---|
|
Sidley |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
